Member list of California Life Sciences Association

Below you find a list of all members of CLSA in alphabetical order.

Results 701 - 720 out of 950 displayed.
 
Sort direction:
Sort direction:
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35 36  37  38  39  40  41  42  43  44  45  46  47  48 »
Protagonist Therapeutics Inc.   
Newark, USA
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. The company focuses on developing novel peptide-based drugs for rare and prevalent diseases, particularly in hematology, inflammation, and immunology. Their lead product Icotrokinra, an oral, gut-restricted IL-23 receptor antagonist peptide for IBD, including ulcerative colitis and Crohn’s disease. Another product Rusfertide, a mimetic of the natural hormone hepcidin, is in development stage for...
Prothena Biosciences Inc.   
Brisbane, USA
Prothena Corp PLC is a clinical biotechnology company focused on protein dysregulation and developing investigational therapeutics for neurodegenerative and rare peripheral amyloid diseases. The company's pipeline includes antibody-based product candidates targeting various indications, such as Amyloid Light-chain amyloidosis, Parkinson's disease, and ATTR amyloidosis. Prothena's product candidates aim to address significant medical needs in these disease areas. The company is working to advance...
Protillion Biosciences   
Carlsbad, USA
Protillion Biosciences is a developer of a high-throughput protein engineering platform designed to discover the next generation of antibody drugs. The company has developed a novel, powerful, and high-throughput protein display platform designed to revolutionize traditional approaches to the design and development of protein-based drugs, enabling healthcare professionals to accelerate the discovery and development of new protein therapeutics.
protocols.io.   
Berkeley, USA
protocols.io is a secure platform for developing and sharing reproducible methods. The company's platform enables scientists to make, exchange, improve, and discuss protocols. They aim to accelerate research by increasing collaboration and sharing among researchers, while improving efficiency.
Provenance Biofabrics   
San Francisco, USA
Provenance Bio is a biotechnology company focused on creating animal-free collagen using advanced protein and synthetic biology approaches. Their mission is to support a more sustainable and compassionate future by producing complex proteins without the need for animals.
Providien Thermoforming   
San Diego, USA
Providien is a medical device contract manufacturer, supplying precision components, assembled devices, manufacturing services & medical injection molding. The company's thermoforming division, Providien Thermoforming, provides aesthetic, complex medical device enclosures and products. Providien Thermoforming specializes in manufacturing aesthetic, multi-part enclosures for the medical device industry. The division focuses on plastic pressure forming, twin sheet forming, thin gauge packaging,...
PRTM-Orange County   
Irvine, USA
PRTM is a management consulting subsidiary of PwC. The firm’s business centers on the areas of operational strategy, supply chain innovation, product innovation, and customer experience innovation.
PTC Therapeutics Inc.   
Warren, USA
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of the mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value...
PTM Therapeutics   
San Carlos, USA
PTM Therapeutics creates and develops therapies for the treatment of chronic diseases and cancer. The company's lead product PTM-001 is a humanized glycan targeting antibody that is being developed for the treatment of Inflammatory Bowel Disease/UC.
Public Library of Science (PLOS)   
San Francisco, USA
PLOS is a nonprofit, Open Access publisher empowering researchers to accelerate progress in science and medicine by leading a transformation in research communication.
PuraCath Medical, Inc.   
Newark, USA
PuraCath Medical, Inc. is dedicated for the dialysis patient by reducing infections related to peritoneal dialysis (PD) and through simplified connection of PD catheters. The FireflyTM catheter connection system is a UV-enabled disinfection technology designed to minimize user compliance.
Pylum Biosciences   
San Carlos, USA
Pylum Biosciences, Inc. is a biotechnology company developing a new class of precision antibacterial medicines. The Avidocin™ platform uses Avidocin™ proteins, a new class of narrow-spectrum bacteria-killing agents, to combat antibiotic resistance and damage to the beneficial gut microbiota. This technology overcomes problems with broad-spectrum antibiotics by precisely targeting only harmful bacteria, such as Clostridium difficile, without harming the healthy, protective bacteria in the...
Qoolabs, Inc.   
Carlsbad, USA
Qoolabs, Inc. is a biotechnology company that develops and supplies monoclonal antibodies, recombinant proteins, research reagents and rapid diagnostic test products. The company also provides antibody discovery, engineering, recombinant antibody production and assay development services using its proprietary QMAb™ platform for research and diagnostic applications.
Qpex Biopharma, Inc.   
San Diego, USA
Qpex Biopharma, Inc. specializes in discovering and developing novel anti-infective therapies to address antimicrobial resistance, with a pipeline focused on treatments for drug-resistant Gram-negative bacterial infections. Its lead programs are based on xeruborbactam, an investigational ultra-broad-spectrum β-lactamase inhibitor developed for both oral and intravenous combination therapies.
Quadriga BioSciences, Inc.   
Los Altos, USA
Quadriga BioSciences is a clinical-stage oncology company developing QBS72S (formerly QBS10072S), a small-molecule chemotherapeutic agent for the targeted treatment of cancer. QBS72S uses the L-type amino acid transporter 1 (LAT1) to cross the blood-brain barrier and enter cancer cells, where it induces DNA damage leading to cell death. The company is developing QBS72S for brain malignancies and other cancers with elevated LAT1 expression.
Quantum Leap Healthcare Collaborative (QLHC)   
San Francisco, USA
Quantum Leap Healthcare Collaborative is a nonprofit healthcare organization that designs and operates innovative clinical trials, including adaptive platform trials, to accelerate the development and evaluation of new treatments and improve patient outcomes.
QuantumCyte, Inc   
Fremont, USA
QuantumCyte, Inc. is a privately held biotechnology company focused on developing automated tissue microdissection technologies for molecular diagnostics and precision medicine. The company's proprietary NextGen Microdissection platform enables the precise identification, enrichment, and extraction of DNA, RNA, and proteins from targeted cells within tissue specimens, including formalin-fixed paraffin-embedded (FFPE) and frozen tissue sections. By isolating clinically relevant cell populations,...
Quebec Trade Office in Silicon Valley   
San Francisco, USA
The Québec Trade Office in Silicon Valley was opened to provide support to small and medium-sized Québec companies, notably technology companies, wishing to expand their business in the Silicon Valley region and Northern California.
R2M Pharma Inc.   
South San Francisco, USA
R2M Pharma is a biotechnology company devoted to the discovery of small molecules preclinical development compounds for the treatment of unmet medical indications.
R3 Vascular Inc.   
Mountain View, USA
R3 Vascular Inc. is a privately held, venture-backed medical device company that develops next-generation bioresorbable vascular scaffolds (BVS) for treating peripheral artery disease (PAD). The company's proprietary platform most notably its MAGNITUDE® drug-eluting scaffold combines the structural support of a traditional metallic stent with a sirolimus coating designed to minimize local blood vessel inflammation. Unlike permanent metal implants, R3 Vascular's ultra-thin polylactic acid polymer...

«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35 36  37  38  39  40  41  42  43  44  45  46  47  48 »

Disclaimer: Any membership totals displayed reflect organizations who have agreed to display their membership information and may not be indicative of CLSA's total member population.

© Biotechgate by Venture Valuation